Skip to content
Home
R&D
Vaccine against Plasmodium vivax malaria
Vaccine against Covid-19
Vaccine against PRRSV
About Us
The company
Our Story
The Team
Advisory board
News
Contact Us
Home
R&D
Vaccine against Plasmodium vivax malaria
Vaccine against Covid-19
Vaccine against PRRSV
About Us
The company
Our Story
The Team
Advisory board
News
Contact Us
Home
R&D
Vaccine against Plasmodium vivax malaria
Vaccine against Covid-19
Vaccine against PRRSV
About Us
The company
Our Story
The Team
Advisory board
News
Contact Us
Home
R&D
Vaccine against Plasmodium vivax malaria
Vaccine against Covid-19
Vaccine against PRRSV
About Us
The company
Our Story
The Team
Advisory board
News
Contact Us
Home
General
ITSL at the IPVS & ESPHM 2016 Conference
ITSL at the IPVS & ESPHM 2016 Conference
bocadil
June 10, 2016
10:07 am
Sergio Montaner, R+D member of ITSL has presented the recenlty published study on new advance in exosome-based PRRSV vaccine development at the
IPVS & ESPHM 2016
Conference in Dublin.